Are you over 18 and want to see adult content?
More Annotations
A complete backup of theperfectloaf.com
Are you over 18 and want to see adult content?
A complete backup of klinikum-hochsauerland.de
Are you over 18 and want to see adult content?
A complete backup of stretta-music.com
Are you over 18 and want to see adult content?
A complete backup of yunikishrine.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of chapmanradio.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of gofurthercycling.co.uk
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of garyscustomoptik.net
Are you over 18 and want to see adult content?
A complete backup of lusttforlife.com
Are you over 18 and want to see adult content?
A complete backup of pandorajewelrysale.us
Are you over 18 and want to see adult content?
A complete backup of sunrisetheme.com
Are you over 18 and want to see adult content?
A complete backup of genesisrefrigeration.in
Are you over 18 and want to see adult content?
A complete backup of radiologyinfo.org
Are you over 18 and want to see adult content?
A complete backup of yellowleafhammocks.com
Are you over 18 and want to see adult content?
Text
INVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
INVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per UNDERSTANDING SARS-COV-2 AND HOST IMMUNE RESPONSE TO … With the COVID-19 global pandemic, there is an urgent need to advance genetic research into the novel coronavirus (SARS-CoV-2), including testing, transmission, treatment, and the immunology and epidemiology of host immune response. Highly accurate long-read sequencing provides multiple benefits for COVID-19 research, including full-length PACBIO LONG-READ SEQUENCING: SEQUENCE WITH CONFIDENCE Metagenomics & Iso-Seq/scIso-Seq Methods. Jacob Brandenburg, PacBio. 12:45 – 12:50 p.m. WVU Core Offerings. Ryan Percifield, WVU Genomics Core Facility. 12:50 – 1:00 p.m. Summary and Q&A. Jacob Brandenburg, PacBio. This event is free, but registration is required – please let us know you are coming by registering now! ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PRESS RELEASES
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
SEC FILING | PACIFIC BIOSCIENCES OF CALIFORNIA Results of Operations and Financial Condition. . On April 29, 202 1, Pacific Biosciences of California, Inc. (the “Company”) announced its financial results for its first fiscal quarter ended March 31, 202 1. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.ANALYST COVERAGE
Pacific Biosciences of California is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Pacific Biosciences of California's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pacific Biosciences of California or its management. PACIFIC BIOSCIENCES LAUNCHES THE SEQUEL IIE SYSTEM TO “The new Sequel IIe System represents the next advance in our technology, and makes HiFi sequencing accessible to any project where high accuracy, long read lengths, and affordability matter,” said Christian Henry, Chief Executive Officer of Pacific Biosciences.“Prior to HiFi sequencing, researchers used multiple technologies and complex analysis methods in order to obtain results SEC FILING | PACIFIC BIOSCIENCES OF CALIFORNIA The address for Dr. Hunkapiller is c/o Pacific Biosciences of California, Inc., 1305 O’Brien Drive, Menlo Park, California 94025. Dr. Hunkapiller has served on our Board of Directors since 2005, including as Chairman of our Board of Directors from 2011 until March 2020 and has served as our Senior Fellow since August 2020.INVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of theINVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of the PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per ANNUAL REPORT & PROXY MATERIALS ANNUAL REPORT & PROXY MATERIALS. Below you will find the Pacific Biosciences’ 2020 Annual Report and the Proxy Statement for the 2021 Annual Meeting of Stockholders. The 2021 Annual Meeting of Stockholders will be held on June 16, 2021. The shareholders will be addressing matters outlined in the 2021 Proxy Statement at the time ofthe Annual
PRESS RELEASES
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
STOCK INFORMATION
The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
CORPORATE GOVERNANCE The Board of Directors of Pacific Biosciences sets high standards for the company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. UNLEASHING THE POWER OF HIFI SEQUENCING HiFi reads from PacBio are transforming sequencing. With their unique combination of high accuracy and long read lengths, HiFi reads produce superior results across a range of applications, from creation of reference-quality de novo assemblies, to comprehensive variant detection and full-length transcript sequencing. Moreover, HiFi data is easy to store and process, dramatically reducing LONG READS VERSUS MORE READS: COMPARING TWO SEQUENCING A longstanding challenge in microbiome research has been achieving the taxonomic resolution needed to generate testable hypotheses about how the gut microbiome impacts human health and disease, and to assess the mechanism and efficacy of specific microbiome interventions. PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of theINVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
INVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ANNUAL REPORT & PROXY MATERIALS ANNUAL REPORT & PROXY MATERIALS. Below you will find the Pacific Biosciences’ 2020 Annual Report and the Proxy Statement for the 2021 Annual Meeting of Stockholders. The 2021 Annual Meeting of Stockholders will be held on June 16, 2021. The shareholders will be addressing matters outlined in the 2021 Proxy Statement at the time ofthe Annual
ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READS In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
PACBIO APAC WEBINAR SERIES 14:00 - 15:00 Singapore Time. PacBio’s HiFi sequencing is currently the best-in-class data type for various genomic applications. Specifically in metagenomics applications, the combination of length and accuracy of HiFi reads allow a much higher resolution of the underlying complex populations. In this webinar, we will providerecommendations
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
STOCK INFORMATION
The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts.PRESS RELEASES
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES FIRST MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021. SEC FILING | PACIFIC BIOSCIENCES OF CALIFORNIA Item 2.02. Results of Operations and Financial Condition. On April 29, 2021, Pacific Biosciences of California, Inc. (the “Company”) announced its financial results for its first fiscal quarter ended March 31, 2021. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporatedherein by
ANALYST COVERAGE
Pacific Biosciences of California is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Pacific Biosciences of California's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pacific Biosciences of California or its management. CORPORATE GOVERNANCE The Board of Directors of Pacific Biosciences sets high standards for the company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
ADVANCING PHARMACOGENOMICS RESEARCH AND THE NEED FOR PacBio highly accurate long-read sequencing – HiFi sequencing – has helped explain and advance the understanding of specific drug-gene interactions, such that there are now a number of actionable pharmacogenomics examples. Allows for comprehensive interrogation of pharmacogenomics genes, detecting all types of variants even inchallenging
PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of theINVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READSPACBIO HIFI READSPACBIO HIFI ASSEMBLYCCS PACBIOPACBIO SEQUEL 2PACBIO SEQUEL IIPACBIO SEQUEL SYSTEM In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLYGUT MICROBIOME AND OBESITYHUMAN GUT MICROBIOMEPACBIO HIFI SEQUENCINGPACBIO HIFI ASSEMBLYPACBIO LONG READ SEQUENCINGPACBIO SEQUENCING 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of the TRANSPARENCY IN SUPPLY CHAIN NOTICE & STATEMENT ON SLAVERY Transparency in Supply Chain Notice & Statement on Slavery and Human Trafficking Pacific Biosciences expects suppliers with whom it does business to comply with all applicable laws, including lawsINVESTOR RELATIONS
Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular EVENTS & PRESENTATIONS The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES FOR APPROXIMATELY Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome; Pacific Biosciences’ Recent Advances with its Sequel SMRT ® Technology, Combined with Illumina’s Infrastructure, will Expand Biological Discovery and Clinical Insight; Long-Read Sequencing Market Opportunity Expected to Grow to $2.5B by 2022 A QUICK GUIDE TO METAGENOMIC ANALYSIS WITH PACBIO HIFI READSPACBIO HIFI READSPACBIO HIFI ASSEMBLYCCS PACBIOPACBIO SEQUEL 2PACBIO SEQUEL IIPACBIO SEQUEL SYSTEM In this webinar we will: Review the different commonly used study designs for metagenomics experiments using the Sequel II System and HiFi reads. Discuss the workflows, tools, and best practices for CCS analysis, shotgun assembly, gene finding, and profiling. Spotlight recent publications and emerging techniques. JOHN MILLIGAN, PH.D. John F. Milligan, PhD has served as the Chair of our board of directors since September 2020. Dr. Milligan had a 29-year career with Gilead, retiring as President and Chief Executive Officer in December2018.
A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLYGUT MICROBIOME AND OBESITYHUMAN GUT MICROBIOMEPACBIO HIFI SEQUENCINGPACBIO HIFI ASSEMBLYPACBIO LONG READ SEQUENCINGPACBIO SEQUENCING 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
RANDY LIVINGSTON
Randy Livingston has been Vice President for Business Affairs and Chief Financial Officer of Stanford University since 2001. Before joining Stanford, Mr. Livingston served as the Executive Vice President, Chief Financial Officer and a Director of OpenTV Corp. from1999 to 2001.
PACIFIC BIOSCIENCES ENABLES REFERENCE-QUALITY DE NOVO MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio RS II Sequencing System, today announced that its Single Molecule, Real-Time (SMRT ®) Sequencing was featured in a number of presentations during last week's Advances in Genome Biology & Technology (AGBT) conference, including demonstrations of the TRANSPARENCY IN SUPPLY CHAIN NOTICE & STATEMENT ON SLAVERY Transparency in Supply Chain Notice & Statement on Slavery and Human Trafficking Pacific Biosciences expects suppliers with whom it does business to comply with all applicable laws, including lawsSTOCK INFORMATION
The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. PACBIO HIFIVIRAL FOR SARS-COV-2 WORKFLOW Protocol: Using this protocol, you can multiplex up to 900 samples and generate HiFi reads that are over 99.9% accurate on the Sequel II or IIe Systems. Please complete this short form and the protocol and accompanying materials will be emailed to you. We will also update you if the protocol is further refined or adapted. How many samples per ANNUAL REPORT & PROXY MATERIALS ANNUAL REPORT & PROXY MATERIALS. Below you will find the Pacific Biosciences’ 2020 Annual Report and the Proxy Statement for the 2021 Annual Meeting of Stockholders. The 2021 Annual Meeting of Stockholders will be held on June 16, 2021. The shareholders will be addressing matters outlined in the 2021 Proxy Statement at the time ofthe Annual
PRESS RELEASES
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May FINANCIAL INFORMATION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. SEC FILING | PACIFIC BIOSCIENCES OF CALIFORNIA As previously disclosed, on February 9, 2021, Pacific Biosciences of California, Inc. (the “Company”) entered into an investment agreement (the “Investment Agreement”) with SB Northstar LP (the “Purchaser”) relating to the issuance and sale to the Purchaser of $900,000,000 in aggregate principal amount of the Company’s 1.50% Convertible Senior Notes due 2028 (the “Notes”). CORPORATE GOVERNANCE The Board of Directors of Pacific Biosciences sets high standards for the company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. A HIFI VIEW: SEQUENCING THE GUT MICROBIOME WITH HIGHLY 1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks. Learn how researchers are using PacBio HiFi sequencing to overcome common challenges in microbiome research, including ambiguous taxonomic assignments and culture-resistant bacteria. Dr. Ashby starts the webinar off with a brief update on PacBio’s metagenomics solutionson the
EMAIL ALERTS SUBSCRIPTION The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. TRANSPARENCY IN SUPPLY CHAIN NOTICE & STATEMENT ON SLAVERY Transparency in Supply Chain Notice & Statement on Slavery and Human Trafficking Pacific Biosciences expects suppliers with whom it doesbusiness
X
QUALITY STATEMENT
Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.X
IMAGE USE AGREEMENT
By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative. Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party. You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images onall copies.
IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES. You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination. I have read and understand, and agree to, the Image Usage Agreement. I disagree and would like to return to the Pacific Biosciences homepage.
Pacific Biosciences
* Products + Services With innovations in sequencing and data analysis tools, PacBio offers the most advanced suite of products and services available. * PacBio Sequel Systems* Consumables
* Analytical Software * SMRT Compatible Products * Certified Service Providers* Research Focus
PacBio’s Single Molecule, Real-Time (SMRT) Sequencing offers the most comprehensive view of genomes for a wide range of research areas. * Human Biomedical Research * Plant and Animal Sciences * Microbiology and Infectious Disease* Applications
PacBio technologies are ideal for a number of sequencing applications, including whole genome sequencing, targeted sequencing, RNA sequencing, and more. * Whole Genome Sequencing * Targeted Sequencing * Complex Populations* RNA Sequencing
* Epigenetics
* SMRT Science
Single Molecule, Real-Time (SMRT) Sequencing technology delivers the highest consensus accuracy with unprecedented read lengths.* SMRT Sequencing
* SMRT Resources
* SMRT Grants
* Support
PacBio provides comprehensive support for sequencing projects through training materials, documentation, and software downloads.* Technical Support
* Training
* Documentation
* Software Downloads* Company
Discover more about PacBio, the development of our Single Molecule, Real-Time (SMRT) Sequencing technology, and how we are helping scientists advance the field of genomics.* About Us
* Leadership
* News + Events
* Investors
* Careers
Contact:
Pricing
Questions
Back To Top
Sequence with Confidence. Pacific Biosciences long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. INTRODUCING THE SEQUEL II SYSTEM Based on our proven Single Molecule, Real-Time (SMRT) Sequencing technology, the new Sequel II System delivers even more highly accurate long reads to accelerate your science. _“In our experience, the Sequel II System was essentially production-ready right out of the box.” _ – LUKE TALLON, SCIENTIFIC DIRECTOR, GENOMICS RESOURCE CENTER AT THE UNIVERSITY OF MARYLAND INSTITUTE FOR GENOME SCIENCESLearn More
DISCOVER THE BENEFITS FOR YOUR RESEARCH FOCUSHUMAN BIOMEDICAL
RESEARCH
Resolve hidden heritability and improve your understanding of geneticdisease
PLANT & ANIMAL
SCIENCES
Accelerate basic research, agricultural improvements, and industrialbiotechnology
MICROBIOLOGY &
INFECTIOUS DISEASE
Improve global health, protect agriculture and livestock, and fueldiscovery research
EXPLORE THE RANGE OF APPLICATIONS APPLY THE VERSATILITY OF SMRT SEQUENCING TO REVEAL NEW INSIGHTSRNA
SEQUENCING
TARGETED SEQUENCING
COMPLEX POPULATIONS
EPIGENETICS
WHOLE GENOME SEQUENCINGVARIANT
DETECTION
RNA
SEQUENCING
TARGETED SEQUENCING
COMPLEX POPULATIONS
EPIGENETICS
WHOLE GENOME SEQUENCINGVARIANT
DETECTION
RNA
SEQUENCING
TARGETED SEQUENCING
SEE WHAT'S NEW
Blog
SMRT Sequencing Helps Crack the Code of Elusive CentromeresPublication
New England Journal of Medicine: Genetic Variation, Comparative Genomics, and the Diagnosis of DiseasePress Release
Beijing-Based Annoroad Increases SMRT Sequencing Capacity to > 1 TbPer Day
Blog
HiFi Reads Add Unparalleled Accuracy to the Long-Read SequencingArsenal
In the News
Lab Compare: Demystifying the Cannabis GenomeSMRT Resources
Webinar Recording: Variant calling and de novo genome assembly withPacBio HiFi reads
Press Release
Pacific Biosciences of California, Inc. Announces Second Quarter 2019Financial Results
Blog
RNA Sequencing SMRT Grant Winner to Help Hone New Therapeutic Strategy in Acute Myeloid LeukemiaIn the News
GEN: Full-length Transcript Sequencing – No Assembly Required -------------------------PUBLICATIONS
PACBIO BLOG
NEWS & EVENTS
CONNECT WITH US
CONTACT PACBIO
FIND A SERVICE PROVIDER LOCATE A DISTRIBUTORRECEIVE UPDATES
GET THE LATEST IN SMRT SEQUENCING NEWS* Customer Login
* Investors
* Media Resources
* Careers
* Privacy Policy
* Legal & Trademarks*
2015-2019, Pacific Biosciences of California, Inc. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0